|
Volumn 23, Issue 11, 2009, Pages 1347-1348
|
Pimecrolimus: A new choice in the treatment of vitiligo?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CLOBETASOL;
PIMECROLIMUS;
ABSENCE OF SIDE EFFECTS;
ACNE;
ADOLESCENT;
ADULT;
CHILD;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DISEASE DURATION;
DRUG EFFICACY;
DRUG SAFETY;
FEMALE;
HUMAN;
LETTER;
MALE;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
SKIN ATROPHY;
SKIN PIGMENTATION;
TELANGIECTASIA;
VITILIGO;
ADMINISTRATION, TOPICAL;
ADOLESCENT;
ADULT;
CHILD;
CHILD, PRESCHOOL;
CLOBETASOL;
DERMATOLOGIC AGENTS;
DOUBLE-BLIND METHOD;
FEMALE;
HUMANS;
MALE;
MIDDLE AGED;
TACROLIMUS;
VITILIGO;
YOUNG ADULT;
|
EID: 70349971667
PISSN: 09269959
EISSN: 14683083
Source Type: Journal
DOI: 10.1111/j.1468-3083.2009.03228.x Document Type: Letter |
Times cited : (10)
|
References (8)
|